NDC11 25021019920
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 25021-0199-20 | 25021-0199 |
| 25021-199-20 | 25021-199 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ertapenem | ERTAPENEM SODIUM | Sagent Pharmaceuticals | 124775ed-1271-4581-be52-b7a08c91283d | 2026-01-09 | Warnings, Adverse reactions | 25021-199 |
| Ertapenem | ERTAPENEM SODIUM | Sagent Pharmaceuticals | 39bd4d41-36f8-4826-a733-a5ad1a531c02 | 2025-08-17 | Warnings, Adverse reactions | 25021-199-20 25021-199 25021019920 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.